Business Description
![Exact Sciences Corp Exact Sciences Corp logo](https://static.gurufocus.com/logos/0C000007JB.png?14)
Exact Sciences Corp
NAICS : 621511
SIC : 8731
ISIN : US30063P1057
Share Class Description:
EXAS: Ordinary SharesDescription
Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening, too.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.26 | |||||
Equity-to-Asset | 0.49 | |||||
Debt-to-Equity | 0.82 | |||||
Debt-to-EBITDA | 1295.11 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1 | |||||
Beneish M-Score | -2.49 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12 | |||||
3-Year EPS without NRI Growth Rate | 29.7 | |||||
3-Year FCF Growth Rate | -27.9 | |||||
3-Year Book Growth Rate | 7.3 | |||||
Future 3-5Y Total Revenue Growth Rate | 12.07 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 22.95 | |||||
9-Day RSI | 25.44 | |||||
14-Day RSI | 27.6 | |||||
6-1 Month Momentum % | -23.55 | |||||
12-1 Month Momentum % | -46.07 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.64 | |||||
Quick Ratio | 1.45 | |||||
Cash Ratio | 0.95 | |||||
Days Inventory | 70.4 | |||||
Days Sales Outstanding | 28.95 | |||||
Days Payable | 40.98 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.4 | |||||
Shareholder Yield % | -1.07 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 73.67 | |||||
Operating Margin % | -9.45 | |||||
Net Margin % | -9.48 | |||||
FCF Margin % | -0.81 | |||||
ROE % | -7.74 | |||||
ROA % | -3.76 | |||||
ROIC % | -4.46 | |||||
ROC (Joel Greenblatt) % | -23.8 | |||||
ROCE % | -3.55 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 2.97 | |||||
PB Ratio | 2.43 | |||||
Price-to-Operating-Cash-Flow | 66.45 | |||||
EV-to-EBIT | -45.63 | |||||
EV-to-Forward-EBIT | -47.1 | |||||
EV-to-EBITDA | 4830.09 | |||||
EV-to-Forward-EBITDA | 216.82 | |||||
EV-to-Revenue | 3.76 | |||||
EV-to-Forward-Revenue | 3.39 | |||||
EV-to-FCF | -465.87 | |||||
Price-to-Median-PS-Value | 0.16 | |||||
Earnings Yield (Greenblatt) % | -2.19 | |||||
FCF Yield % | -0.27 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:EXAS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Exact Sciences Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 2,534.84 | ||
EPS (TTM) ($) | -1.316 | ||
Beta | 1.52 | ||
Volatility % | 51.14 | ||
14-Day RSI | 27.6 | ||
14-Day ATR ($) | 2.221122 | ||
20-Day SMA ($) | 45.893 | ||
12-1 Month Momentum % | -46.07 | ||
52-Week Range ($) | 41.081 - 100.77 | ||
Shares Outstanding (Mil) | 184.53 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Exact Sciences Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Exact Sciences Corp Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Exact Sciences Corp Frequently Asked Questions
What is Exact Sciences Corp(EXAS)'s stock price today?
The current price of EXAS is $41.33. The 52 week high of EXAS is $100.77 and 52 week low is $41.08.
When is next earnings date of Exact Sciences Corp(EXAS)?
The next earnings date of Exact Sciences Corp(EXAS) is 2024-08-01 Est..
Does Exact Sciences Corp(EXAS) pay dividends? If so, how much?
Exact Sciences Corp(EXAS) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |